Fidelity Investments’s iTeos Therapeutics ITOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$526K Buy
52,740
+48,861
+1,260% +$487K ﹤0.01% 2945
2025
Q1
$23.2K Sell
3,879
-6,856
-64% -$40.9K ﹤0.01% 4171
2024
Q4
$82.4K Buy
10,735
+8,886
+481% +$68.2K ﹤0.01% 3631
2024
Q3
$18.9K Sell
1,849
-319
-15% -$3.26K ﹤0.01% 4193
2024
Q2
$32.2K Buy
2,168
+437
+25% +$6.49K ﹤0.01% 3836
2024
Q1
$23.6K Sell
1,731
-139,811
-99% -$1.91M ﹤0.01% 3945
2023
Q4
$1.55M Buy
141,542
+879
+0.6% +$9.63K ﹤0.01% 2356
2023
Q3
$1.54M Sell
140,663
-54
-0% -$591 ﹤0.01% 2352
2023
Q2
$1.86M Sell
140,717
-71,998
-34% -$953K ﹤0.01% 2335
2023
Q1
$2.9M Sell
212,715
-142,283
-40% -$1.94M ﹤0.01% 2266
2022
Q4
$6.93M Sell
354,998
-91,279
-20% -$1.78M ﹤0.01% 2025
2022
Q3
$8.5M Buy
446,277
+15,081
+3% +$287K ﹤0.01% 1974
2022
Q2
$8.88M Sell
431,196
-182,341
-30% -$3.76M ﹤0.01% 2019
2022
Q1
$19.7M Sell
613,537
-181,944
-23% -$5.86M ﹤0.01% 1784
2021
Q4
$37M Sell
795,481
-9,600
-1% -$447K ﹤0.01% 1550
2021
Q3
$21.7M Sell
805,081
-5,700
-0.7% -$154K ﹤0.01% 1806
2021
Q2
$20.8M Sell
810,781
-9,300
-1% -$239K ﹤0.01% 1837
2021
Q1
$28M Buy
820,081
+83,200
+11% +$2.84M ﹤0.01% 1641
2020
Q4
$24.9M Buy
736,881
+98,681
+15% +$3.34M ﹤0.01% 1610
2020
Q3
$15.7M Buy
+638,200
New +$15.7M ﹤0.01% 1676